Europe’s winter energy crunch may already be underway. Two U.S. stocks that may benefitOctober 2, 2026
Viatris to contribute its biosimilars portfolio to Biocon Biologics for up to $3.335 billion, shares jump 4% premarket Finances February 28, 2022 Viatris Inc. VTRS, +4.38%, the corporate fashioned by the merger of Mylan and Pfizer Inc. PFE, +3.83% unit Upjohn in…
